Skip to content

Effect of dexamethasone combined with esketamine on postoperative fatigue in patients undergoing laparoscopic total hysterectomy

Effect of dexamethasone combined with esketamine on postoperative fatigue in patients undergoing laparoscopic total hysterectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095776
Enrollment
Unknown
Registered
2025-01-13
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Fatigue

Interventions

Dexamethasone group:Open venous access is followed by 8 mg of dexamethasone
Dexamethasone combined with esketamine group:Open venous access is followed by 8 mg of dexamethasone.After induction, 0.25mg/kg esketamine was administered and the intraoperative rate of 0.125mg/kg/h

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective laparoscopic total hysterectomy; 2. ASA grade I - II; 3. Aged 18 to 65 years old; 4. BMI 18-30kg/m^2.

Exclusion criteria

Exclusion criteria: 1.The uterine lesion was malignant; 2.Patients with preoperative fatigue; 3. allergy and contraindications to dexamethasone drugs(Patients with active tuberculosis, thrombosis, gastric and duodenal ulcers, abnormal electrolyte metabolism, myocardial infarction, glaucoma; Patients with diabetes mellitus and poor glycemic control);4.Allergy and contraindication to esketamine; (Patients with severe elevation of intracranial pressure; People with untreated or poorly controlled high blood pressure; Patients with glaucoma; Patients with untreated or undertreated hyperthyroidism) 5.Complicated with severe cardiovascular disease (such as myocardial infarction, heart failure, malignant arrhythmia, Third-degree atrioventricular block, etc.), kidney disease (glomerular filtration rate =2mg/dl); 6. Those who were given any glucocorticoids 3 months before surgery; Recent antidepressant use or other antidepressant treatment;7.History of substance abuse, mental illness, communication disorders, etc.

Design outcomes

Primary

MeasureTime frame
Identity consequence fatigue scale;

Secondary

MeasureTime frame
Christensen fatigue score;Time from the end of the operation to extubation;Perioperative propofol, remifentanil consumption;Intraoperative vasoactive drug use;Incidence of postoperative nausea and vomiting;Remedial analgesics after surgery;VAS pain score;Pittsburgh Sleep Quality Index;The first time of the postoperative exhaust;Perioperative adverse reactions;

Countries

China

Contacts

Public ContactGuanglei Wang

Affiliated Hospital of Xuzhou Medical University

13852087156@163.com+86 138 5208 7156

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026